A meta-analysis that evaluated the effects of thiazolidinediones for the treatment of patients with prediabetes or T2DM combined with Nonalcoholic fatty liver disease (NAFLD) found that pioglitazone significantly improved insulin sensitivity and the results of liver histology. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.